Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Single-Cell Transfection Tool Enables Added Control for Biological Studies

Published: Thursday, May 23, 2013
Last Updated: Thursday, May 23, 2013
Bookmark and Share
Northwestern University researchers have developed a new method for delivering molecules into single, targeted cells through temporary holes in the cell surface.

The technique could find applications in drug delivery, cell therapy, and related biological fields.
Bulk electroporation — a technique used to deliver molecules into cells through reversible nanopores in the cell membrane that are caused by exposing them to electric pulses — is an increasingly popular method of cell transfection. (Cell transfection is the introduction of molecules, such as nucleic acids or proteins, into a cell to change its properties.)

However, because bulk electroporation applies electric pulses to a bulk cell solution, it results in heterogeneous cell populations and often low cell viability. To solve these problems, Northwestern University researchers have developed a novel tool for single-cell transfection.

The new method, called nanofountain probe electroporation (NFP-E), allows researchers to deliver molecules into targeted cells through temporary nanopores in the cell membrane created by a localized electric field applied to a small portion of the cell. The method enables researchers to control dosage by varying the duration of the electric pulses, which provides unprecedented control of cell transfection.

“This is really exciting,” said Horacio Espinosa, James and Nancy Farley Professor of Manufacturing and Entrepreneurship at Northwestern’s McCormick School of Engineering and one of the paper’s authors. “The ability to precisely deliver molecules into single cells is needed for biotechnology researchers to advance the state-of-the-art in therapeutics, diagnostics, and drug delivery toward the promise of personalized medicine.”

A paper describing the research, “Nanofountain Probe Electroporation (NFP-E) of Single Cells,” was published May 7 in the journal Nano Letters.

NFP-E is based on nanofountain probe (NFP) technology developed in Espinosa’s lab. The NFP-E chip consists of an array of microfabricated cantilever probes with integrated microfluidic channels. The probe has previously been used for high-speed nanopatterning of proteins and nanoparticles for drug delivery studies.

The new single-cell transfection application couples the probe with an electrode and fluid control system that can be easily connected to a micromanipulator or atomic force microscope for position control. This integrated system allows the entire transfection process and post-transfection cell response to be monitored by an optical microscope.

The NFP-E system is being developed for commercialization by iNfinitesimal LLC, a Northwestern spin-off company founded by Espinosa, and is expected to be available in late 2013.

The technique is proving to be extremely robust and multi-functional. Researchers have used the NFP-E chip to transfect HeLa cells with polysaccharides, proteins, DNA hairpins, and plasmid DNA with single-cell selectivity, high transfection efficiency (up to 95%), qualitative dosage control, and very high viability (up to 92%).

In addition to Espinosa, authors of the research paper include Wonmo Kang, Fazel Yavari, Majid Minary-Jolandan, Juan P. Giraldo-Vela, Asmahan Safi, Rebecca McNaughton, and Victor Parpoil. The research was supported by the National Science Foundation and the National Institutes of Health.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Blood Test To Diagnose Depression
Test identifies nine blood markers tied to depression; predicts who will benefit from therapy.
Thursday, September 18, 2014
Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
Detecting When Hormone Treatment for Breast Cancer Stops Working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
Packaging and Unpacking of the Genome
New research improves understanding of the importance of histone replacement.
New Way to Find DNA Damage
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
How Different Treatments for Crohn's Effect the Microbiome
Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Charting the 'Genomic Biography' of Leukemia
A new study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard offers a glimpse of the wealth of information that can be gleaned by combing the genome of a large collection of leukemia tissue samples.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos